天士力交出华润入主后首份成绩单:下滑趋势延续,股价跌破收购价

子弹财观
Feb 28

出品 | 子弹财经作者 | 张珏编辑 | 蛋总美编 | 倩倩审核 | 颂文2025年3月,医药行业的目光曾聚焦于一场重磅的并购交易。华润三九以62.12亿元现金正式完成了受让天士力医药集团股份有限公司28%股份的过户登记。通过这一交易,中成药巨头天士力的实际控制人由创始人闫希军家族变更为中国华润。这笔被视为“中药双雄”合并的交易被寄予厚望,然而华润入主后的第一年(即2025年),天士力交出的首份“...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10